SHARE (Sharing Goals and Preferences) Study
1 other identifier
interventional
53
1 country
3
Brief Summary
This research study is evaluating the usefulness of a video and questionnaire to help cancer patients think about the goals of their care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2017
CompletedFirst Posted
Study publicly available on registry
January 5, 2018
CompletedStudy Start
First participant enrolled
July 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedMarch 17, 2022
March 1, 2022
1.2 years
December 20, 2017
March 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Enrollment
% of patients invited to participate who choose to enroll
2 years
Overall rating of intervention
% who rate intervention as good/very good/excellent.
1 month
Would recommend intervention to others
% who would recommend intervention to others with cancers like theirs
1 month
Secondary Outcomes (8)
Preferred format for viewing video and completing questionnaire
1 month
Patient anxiety
1 month
Patient distress
1 month
Patient depression
1 month
Hope
1 month
- +3 more secondary outcomes
Study Arms (1)
More Good Days video&brief questionnaire
EXPERIMENTAL* Participants will watch the More Good Days video and will be given a brief questionnaire and wallet card to help identify their goals and preferences about information and care * The More Good Days video is developed to help patients with advanced cancer think about what a good day means to them and to help them think about questions they may have for their physicians when discussing treatments. * The 3-page brief questionnaire is designed to help patients identify their preferences about information and care and to help encourage a conversation between patients and their doctors and health care team about their goals and preferences * The wallet card will help patients think about questions they may want to ask their providers when considering treatments.
Interventions
Help patients with advanced cancer think about what a good day means to them and to help them think about questions they may have for their physicians when discussing treatments
Eligibility Criteria
You may qualify if:
- Patient who are receiving treatment at:
- DFCI in the thoracic oncology group
- DFCI-affiliated St. Elizabeth's Hospital and have progressed on 2nd line or later-line systemic therapies (chemotherapy, immunotherapy, biological, or targeted therapies)
- Clinicians' schedules to identify patients with metastatic cancers who are considering or pursuing additional palliative therapy
You may not qualify if:
- Patients who are not interested in the study
- Patients of physicians who opt out of participating
- Patients whose physicians did not opt out, but whose physician does not think they are well suited for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dana-Farber Cancer Institutelead
- American Cancer Society, Inc.collaborator
- Harvard Medical School (HMS and HSDM)collaborator
Study Sites (3)
Dana Farber Cancer Institute at St Elizabeth
Boston, Massachusetts, 02062, United States
Nancy Keating
Boston, Massachusetts, 02115, United States
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Related Publications (1)
Wright AA, Thompson E, Nguyen MV, Wescott P, Barry MJ, Lathan CS, Keating NL. The SHARE Study: Pilot Study of a Communication Intervention Designed to Elicit Advanced-Stage Cancer Patients' Preferences and Goals. J Palliat Med. 2022 Nov;25(11):1646-1654. doi: 10.1089/jpm.2021.0655. Epub 2022 Jun 23.
PMID: 35736783DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Nancy L Keating, MD
Harvard Medical School (HMS and HSDM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 20, 2017
First Posted
January 5, 2018
Study Start
July 23, 2018
Primary Completion
October 18, 2019
Study Completion
March 15, 2022
Last Updated
March 17, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share